Trial Profile
Effects of Irbesartan100mg/Trichlormethiazide1mg combination tablet on circadian and nocturnal blood pressure
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Irbesartan/trichlormethiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Shionogi
- 18 Sep 2015 Status changed from recruiting to discontinued, as reported by University Hospital Medical Information Network - Japan record.
- 11 Oct 2014 New trial record